12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

This study has been terminated.

( At this time it is felt that we will not gain further information from an additional patients. )

Study NCT00004058 Information provided by University of Medicine and Dentistry New Jersey

First Received: December 10, 1999 Last Updated: January 25, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	November 2004
Primary Completion Date:	November 2004 (Final data collection date for primary outcome measure)